1Elbein SC, Wegner K, Kahn SE. Reduced β-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type 2 diabetic kindreds. Diabetes Care,2000, 23:221-227.
2Kahn SE, Prige0b RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Diabetes, 1993, 42:1663-1672.
3Bergman RN. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes, 1989, 38: 1512-1527.
4Saad MF, Steil GM, Kades WW, et al. Difference between the tobutamide-boosted and the insulin-modified minimal model protocols. Diabetes, 1997, 46: 1167-1171.
5Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type Ⅱ diabetes mellitus. Diabetologia, 2001,44 :929-945.
6Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus Diabetes Metab Res Rev, 2001,17: 164-174.
7Campbell PJ, Carlson MG : Impact of obesity on insulin action in NIDDM. Diabetes, 1993,42 .. 405-410.
